Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Preethi Gopinath, The Princess Alexandra Hospital NHS Trust, Consultant Histopathologist, Pathology Portal Editorial board member - Dr Sarah Lower, Mid and South Essex Hospitals NHS Trust, Consultant Histopathologist, Chief Examiner FRCPath Part 2 Histopathology
Authored by Alyn Cratchley, Leeds Teaching Hospitals, UK Liver Pathology Group Secretary - Tim Kendall, Edinburgh, Consultant Histopathologist (Speaker)
Authored by Nelly Selem, Universidad Nacional Autónoma de México - Jose Molina Mora, University of Costa Rica - Rebeca Campos Sáchez, University of Costa Rica - Cindy Aguilar Bartels, University of Costa Rica - Lizzie Bridget Divala, EMBL's European Bioinformatics Institute (EMBL-EBI) EMBL-EBI Main Building, Wellcome Genome Campus, - Kim Tamara Gurwitz, EMBL's European Bioinformatics Institute (EMBL-EBI) EMBL-EBI Main Building, Wellcome Genome Campus, - Mahesh Prahladan, Pathology Portal
Authored by James Stephenson, EMBL's European Bioinformatics Institute (EMBL-EBI) EMBL-EBI Main Building, Wellcome Genome Campus, - Emily Bowler-Barnett, EMBL's European Bioinformatics Institute (EMBL-EBI) EMBL-EBI Main Building, Wellcome Genome Campus, - Mahesh Prahladan, Pathology Portal
Authored by Jose Molina Mora, University of Costa Rica - Rebeca Campos Sáchez, University of Costa Rica - Cindy Aguilar Bartels, University of Costa Rica - Kim Tamara Gurwitz, EMBL's European Bioinformatics Institute (EMBL-EBI) EMBL-EBI Main Building, Wellcome Genome Campus, - Lizzie Bridget Divala, EMBL's European Bioinformatics Institute (EMBL-EBI) EMBL-EBI Main Building, Wellcome Genome Campus, - Mahesh Prahladan, Pathology Portal
Authored by Daniel Rice, EMBL's European Bioinformatics Institute (EMBL-EBI) EMBL-EBI Main Building, Wellcome Genome Campus, - Emily Bowler-Barnett, EMBL's European Bioinformatics Institute (EMBL-EBI) EMBL-EBI Main Building, Wellcome Genome Campus, - Flaminia Zane, EMBL's European Bioinformatics Institute (EMBL-EBI) EMBL-EBI Main Building, Wellcome Genome Campus, - Mahesh Prahladan, Pathology Portal
Authored by Flavio E. Spetale, CIFASIS CONICET - Universidad Nacional de Rosario - Jose Molina Mora, University of Costa Rica - Rebeca Campos Sáchez, University of Costa Rica - Cindy Aguilar Bartels, University of Costa Rica - Kim Tamara Gurwitz EMBL-EBI, EMBL's European Bioinformatics Institute (EMBL-EBI) EMBL-EBI Main Building, Wellcome Genome Campus, - Lizzie Bridget Divala, EMBL's European Bioinformatics Institute (EMBL-EBI) EMBL-EBI Main Building, Wellcome Genome Campus, - Mahesh Prahladan, Pathology Portal
Authored by Eliot Ragueneau, EMBL's European Bioinformatics Institute (EMBL-EBI) , Grenoble - Susie Huget, iMEAN, National Institute of Applied Sciences of Toulouse, Toulouse - Flaminia Zane, EMBL's European Bioinformatics Institute (EMBL-EBI) EMBL-EBI Main Building, Wellcome Genome Campus, - Mahesh Prahladan, Pathology Portal
Authored by Michele Magrane, EMBL's European Bioinformatics Institute (EMBL-EBI) EMBL-EBI Main Building, Wellcome Genome Campus, - Emily Bowler-Barnett, EMBL's European Bioinformatics Institute (EMBL-EBI) EMBL-EBI Main Building, Wellcome Genome Campus, - Mahesh Prahladan, Pathology Portal
